Search results
Results from the WOW.Com Content Network
Media reporting on statins is often negative, and patient leaflets inform patients that rare but potentially serious muscle problems can occur during statin treatment. These create expectations of harm. Nocebo symptoms are real and bothersome and are a major barrier to treatment.
The lipid hypothesis (also known as the cholesterol hypothesis) is a medical theory postulating a link between blood cholesterol levels and the occurrence of cardiovascular disease. A summary from 1976 described it as: "measures used to lower the plasma lipids in patients with hyperlipidemia will lead to reductions in new events of coronary ...
Ezetimibe/atorvastatin (trade names Liptruzet, Atozet) is a cholesterol lowering combination drug.In the United States, it was approved in May 2013, by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet. [1]
That can lead to “increases in our LDL ('bad') cholesterol, which in turn increases the risk of heart disease and strokes,” Wood adds. Myth #5: Protein doesn’t lead to weight gain
In moderate amounts omega-6 has been shown to help lower bad cholesterol and can reduce the risk of heart disease and stroke. Heart healthy recipes and expert tips to boost your diet
A 2023 review of studies by researchers at the Federal University of São Paulo found children who consume more UPFs are more likely to be overweight and develop cardiovascular health issues and ...
Fat Head is a 2009 American documentary film directed by and starring comedian Tom Naughton. The film seeks to refute both the documentary Super Size Me and the lipid hypothesis, a theory of nutrition started in the early 1950s in the United States by Ancel Keys and promoted in much of the Western world.
Malhotra denounces what he calls the government's "obsession" with levels of total cholesterol, which, he says, has led to the overmedication of millions of people with statins, and has diverted attention from the "more egregious" risk factor of atherogenic dyslipidaemia. [66] He has questioned the worth of statins, and campaigned against their ...